COVID-19 update: We hope you are staying safe and healthy in this unprecedented time. During this time, Grossman Green PLLC continues to represent our existing clients and we are accepting new clients. In accordance with CDC guidelines and the Governor’s Orders, our attorneys are practicing social distancing and primarily working remotely. We are available to speak to new and existing clients via video conferencing, phone calls, and e-mail. If you would like to speak to someone from our office, please call 502-657-7100, e-mail us through our website, or reach out to us on Facebook. We will continue to pursue justice for our clients and appreciate your patience and understanding during this time.

Banner Image

A Legal Team Equipped To Handle Serious Personal Injury Matters

  1. Home
  2.  » 
  3. Product Defects Causing Injury
  4.  » Ranitidine Drugs (Zantac)

Ranitidine Drugs (Zantac)

FDA Pulls Ranitidine Drugs (Zantac) Off Market Because of Cancer Risk

Effective April 1, 2020 the Food and Drug Administration requested the removal of ranitidine products (brand name Zantac) from the market. These popular over-the-counter products have been used as an antacid for reflux and other intestinal conditions for decades. The FDA on April 1, 2020 said:

“[I]t is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications
(commonly known by the brand name Zantac).”

For further information see:

Learn the difference we can make

If you or a loved one have used these products in the past have been diagnosed with cancer, contact the lawyers at Grossman Green PLLC to evaluate whether you may have a potential case.